{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:41:50Z","timestamp":1787611310550,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.canlet.2011.09.006","type":"journal-article","created":{"date-parts":[[2011,9,13]],"date-time":"2011-09-13T10:56:48Z","timestamp":1315911408000},"page":"211-217","source":"Crossref","is-referenced-by-count":21,"title":["TSC1\/TSC2 inactivation inhibits AKT through mTORC1-dependent up-regulation of STAT3-PTEN cascade"],"prefix":"10.1016","volume":"313","author":[{"given":"Xiaojun","family":"Zha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongdong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaozong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huangxuan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2011.09.006_b0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1749-6632.2009.05117.x","article-title":"The tuberous sclerosis complex","volume":"1184","author":"Orlova","year":"2010","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.canlet.2011.09.006_b0010","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2011.09.006_b0015","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1101\/gad.1110003","article-title":"Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling","volume":"17","author":"Inoki","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2011.09.006_b0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","article-title":"Defining the role of mTOR in cancer","volume":"12","author":"Guertin","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2011.09.006_b0025","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ng0497-356","article-title":"Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers","volume":"15","author":"Steck","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2011.09.006_b0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0092-8674(00)81780-8","article-title":"Negative regulation of PKB\/Akt-dependent cell survival by the tumor suppressor PTEN","volume":"95","author":"Stambolic","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2011.09.006_b0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-8674(00)81663-3","article-title":"Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association","volume":"99","author":"Lee","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2011.09.006_b0040","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0092-8674(00)80674-1","article-title":"The multiple roles of PTEN in tumor suppression","volume":"100","author":"Di Cristofano","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2011.09.006_b0045","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cell.2008.04.013","article-title":"Tenets of PTEN tumor suppression","volume":"133","author":"Salmena","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2011.09.006_b0050","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2011.09.006_b0055","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1172\/JCI200317222","article-title":"Loss of Tsc1\/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR","volume":"112","author":"Zhang","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2011.09.006_b0060","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1172\/JCI28984","article-title":"PDGFRs are critical for PI3K\/Akt activation and negatively regulated by mTOR","volume":"117","author":"Zhang","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2011.09.006_b0065","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1083\/jcb.200403069","article-title":"The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins","volume":"166","author":"Harrington","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.canlet.2011.09.006_b0070","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.cub.2004.08.026","article-title":"Inappropriate activation of the TSC\/Rheb\/mTOR\/S6K cassette induces IRS1\/2 depletion, insulin resistance, and cell survival deficiencies","volume":"14","author":"Shah","year":"2004","journal-title":"Curr. Biol."},{"key":"10.1016\/j.canlet.2011.09.006_b0075","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1128\/MCB.18.5.2553","article-title":"Stat3 activation is required for cellular transformation by v-src","volume":"18","author":"Bromberg","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.canlet.2011.09.006_b0080","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1158\/0008-5472.CAN-03-3609","article-title":"Perturbed IFN-gamma-Jak-signal transducers and activators of transcription signaling in tuberous sclerosis mouse models: synergistic effects of rapamycin-IFN-gamma treatment","volume":"64","author":"El-Hashemite","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.09.006_b0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1172\/JCI37964","article-title":"Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3\/p63\/Jagged\/Notch cascade","volume":"120","author":"Ma","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2011.09.006_b0090","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1523\/JNEUROSCI.5540-06.2007","article-title":"A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival","volume":"27","author":"Meikle","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.canlet.2011.09.006_b0095","doi-asserted-by":"crossref","first-page":"8313","DOI":"10.1074\/jbc.C500451200","article-title":"TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase","volume":"281","author":"Chong-Kopera","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2011.09.006_b0100","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.cell.2006.06.055","article-title":"TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth","volume":"126","author":"Inoki","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2011.09.006_b0105","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR complex 1","volume":"39","author":"Duvel","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2011.09.006_b0110","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nri1995","article-title":"Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment","volume":"7","author":"Yu","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2011.09.006_b0115","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1006\/mcne.2002.1184","article-title":"Tsc2 null murine neuroepithelial cells are a model for human tuber giant cells, and show activation of an mTOR pathway","volume":"21","author":"Onda","year":"2002","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.canlet.2011.09.006_b0120","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1126\/science.1199484","article-title":"Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling","volume":"332","author":"Yu","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.canlet.2011.09.006_b0125","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.1199498","article-title":"The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling","volume":"332","author":"Hsu","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.canlet.2011.09.006_b0130","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1101\/gad.1314605","article-title":"Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2","volume":"19","author":"Manning","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2011.09.006_b0135","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1101\/gad.1314405","article-title":"Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression","volume":"19","author":"Ma","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2011.09.006_b0140","doi-asserted-by":"crossref","first-page":"27790","DOI":"10.1074\/jbc.M109.028860","article-title":"TSC2 deficiency increases PTEN via HIF1alpha","volume":"284","author":"Mahimainathan","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2011.09.006_b0145","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1097-2765(01)00323-9","article-title":"Regulation of PTEN transcription by p53","volume":"8","author":"Stambolic","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2011.09.006_b0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1158\/0008-5472.CAN-10-1668","article-title":"Lactate dehydrogenase B is critical for hyperactive mTOR-mediated tumorigenesis","volume":"71","author":"Zha","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.09.006_b0155","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.4161\/cc.10.7.15063","article-title":"mTOR upregulation of glycolytic enzymes promotes tumor development","volume":"10","author":"Zha","year":"2011","journal-title":"Cell Cycle"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383511005362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383511005362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T03:55:44Z","timestamp":1543550144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383511005362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0304383511005362"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2011.09.006","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}